A retrospective study assessing the characteristics and therapeutic management of patients with HER2-positive early breast cancer patients
Latest Information Update: 20 Nov 2020
At a glance
- Drugs Trastuzumab (Primary)
- Indications Carcinoma; Early breast cancer
- Focus Therapeutic Use
- Acronyms KADor
- 20 Nov 2020 New trial record
- 19 Nov 2020 Results presented at the 23rd Annual European Congress of the International Society for Pharmacoeconomics and Outcomes Research
- 19 Nov 2020 Results presented at the 23rd Annual European Congress of the International Society for Pharmacoeconomics and Outcomes Research